During the first respiratory syncytial virus (RSV) season in which a maternal vaccine and a monoclonal antibody for infants ...

By Dennis Thompson HealthDay ReporterTUESDAY, May 6, 2025 (HealthDay News) -- Newborns can be effectively protected against ...

HealthDay News — In a recent study of a population of infants, published online May 6 in Pediatrics, 72% of infants were found to be immunized against respiratory syncytial virus (RSV).

Saskatchewan is expanding its infant RSV immunization program to include all babies born one month before and during RSV ...

ACIP is recommending that adults aged 50 to 59 years who are at increased risk for severe RSV disease receive a single dose of an RSV vaccine.

A meta-analysis indicates that the monoclonal antibody nirsevimab offers significant real-world protection against severe ...

Nirsevimab, a monoclonal antibody, is highly effective in real-world conditions at preventing severe respiratory syncytial ...

Young children with chronic conditions are more likely to be hospitalized for respiratory syncytial virus (RSV) than healthy children, according to a new study.

Saskatchewan is expanding its infant immunization program to protect all newborns from Respiratory Syncytial Virus (RSV) ...

RSV infects the lungs, causing pneumonia or bronchiolitis. While most children recover from RSV, it can be fatal, especially ...

Young children with chronic conditions are more likely to be hospitalized for respiratory syncytial virus (RSV) than healthy children, according to a new study. The research will be presented at ...

A recent study revealed that newborns can be easily protected against respiratory syncytial virus infection by using the ...